# name
Editorial: Autoinflammatory Diseases: From Genes to Bedside

# metadata.dc.description.abstract[].value
The year 2019 marked the 20th anniversary of the formal recognition of autoinflammatory diseases as a distinct group of rheumatological conditions, following the identification of the gene mutated in patients with a dominantly inherited periodic fever known as familial Hibernian fever (FHF) (1). This nosological concept was introduced by one of the founders of the field, Dr. Daniel Kastner. Prior to this time, the only recognized periodic fever disease was familial Mediterranean fever (FMF) and patients presenting with similar symptoms, irrespective of inheritance pattern, were suspected to have a variant FMF. Most patients, with exception for FMF, were treated with NSAID, glucocorticoids alone, or in a combination with immunosuppressive agents. These chronic life-long conditions negatively impacted patients' quality of life and were associated with significant morbidity and mortality, partially due to treatment-related side effects. The early advances in the field of autoinflammation were driven by the ascertainment of families with inflammatory phenotypes segregating either as a recessive (FMF) or dominantly (FHF) inherited trait. This allowed for linkage mapping, positional cloning and candidate gene screening even before the completion of human genome sequencing project in 2003. These gene-hunting projects were laborious and time-consuming, but nonetheless successful and led to identification of the first three genes associated with autoinflammatory diseases: MEFV, TNFRSF1A, and CIAS1/NLRP3.

# metadata.dc.relation.ispartof[].value
Frontiers in Immunology, 2020, vol. 11, p. 117

# metadata.dc.rights[].value
cc-by (c) Aksentijevich, Ivona et al., 2020

# metadata.dc.source[].value
Articles publicats en revistes (Medicina)

# metadata.dc.title[].value
Editorial: Autoinflammatory Diseases: From Genes to Bedside